In vivo CRO Market Size, Trends, SWOT, PEST, Porter’s Analysis, For 2020

Rising frequency of outsourcing RD activities by the major pharmaceutical companies is driving the market revenue growth

The global in vivo CRO market size reached USD 3.61 Billion in 2020 and is expected to reach USD 6.44 Billion in 2028 and register a CAGR of 8.6% over the forecast period, according to latest analysis by Reports and Data. The in vivo CRO market revenue growth is fueled by various factors including increasing demand for the CROs (Contract Research Organization) in pharmaceutical drug development, rising price competition among companies, and growing requirement to reduce cost combined with rising demand for advanced products. Additionally, changing regulatory policies in several organizations, and increasing chronic medical conditions are some of the factors also expected to contribute to the revenue growth of the global in vivo CRO market during the forecast period. Furthermore, the in vivo CRO market revenue growth is increasing at a significant extent, as drug manufacturers increases their pipeline products in order to develop as well as manufacture new molecule to sustain in the market with good profit, and with a patent product.

In vivo CRO refers to the preclinical testing performed for disease pathology and drug discovery. They provide valuable information about the collection and investigation of data for the development of new drugs required in the treatment of several indications such as diabetes, autoimmune disorders, cancer, and others. Moreover, Contract Research Organization (CRO) services benefit various sponsors/manufacturers to focus completely on the production capacity, augmenting their in-house processes. Furthermore, the availability of a wide range of services from drug discovery to post-marketing surveillance has made it easy for small-scale and mid-size biotechnological and pharmaceutical companies in outsourcing other services which are beyond their core expertise.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1634

The report provides comprehensive assessment of the market covering key elements such as revenue estimations, cost analysis, import/export, production and consumption trends, CAGR, gross margin, and supply demand patterns. It also sheds light on recent technological developments, product advancements, and research and development activities in the region.

The report examines the key players operating in the market along with their market position, market share, revenue, gross margin, and business strategies. SWOT analysis and Porter’s Five Forces Analysis are used to examine and assess the market and its players. It also covers recent mergers and acquisitions, joint ventures, collaborations, agreements, partnerships, and product launches and brand promotions.

Key companies profiled in the report include:

Pharmaceutical Product Development, LLC (PPD), Quintiles, ICON Plc., Parexel International, American Preclinical Services, LLC, Covance Inc., Theorem Clinical research, WuXi AppTec, Inc., inVentiv Health, Evotec (US), Inc., and Charles River Laboratories.

Order this Report @ https://www.reportsanddata.com/report-pricing/1634

Market Segmentation by Types:

Product Type Outlook (Revenue, USD Billion, 2018 - 2028)

Rodent Based

Rats
Mice
Others

Non-Rodent Based

Hamsters
Guinea Pigs
Gerbils
Others

GLP Type Outlook (Revenue, USD Billion, 2018 - 2028)

Non GLP

In House
Outsourcing

GLP Toxicology

In House
Outsourcing

Indication Outlook (Revenue, USD Billion, 2018 - 2028)

Autoimmune/ Inflammatory Conditions

Rheumatoid Arthritis
Multiple Sclerosis
Osteoarthritis
Irritable Bowel Syndrome
Others

Pain Management

Chronic Pain
Acute Pain

Oncology

Blood Cancer
Solid Tumor

Syngeneic Model
Patient Derived Xenograft
Xenograft

Others

CNS conditions

Epilepsy
Parkinson’s Disease
Huntington’s Disease
Stroke
Traumatic Brain Injury
ALS
Muscle Regeneration
Others

Diabetes
Obesity
Others

Regional analysis covers in-depth analysis of analysis of the revenue, market share, and growth rate of the global In vivo CRO market in each region for the forecast period of 2021-2028. The report covers production and consumption rate, current and emerging trends, import/export, supply and demand, and presence of key players in each region.

Request customization of Report @ https://www.reportsanddata.com/request-customization-form/1634

North America

U.S.
Canada
Mexico

Europe

Germany
U.K.
Italy
France
BENELUX
Rest of Europe

Asia Pacific

China
India
Japan
South Korea
Rest of APAC

Latin America

Brazil
Rest of LATAM

Middle East Africa

Saudi Arabia
U.A.E.
South Africa
Rest of MEA

Further key findings in the report

Based on product type, the rodent based in vivo CRO testing segment accounted for the largest revenue share in the global market in 2020. Factors such as better correlation with the human system, and abundant availability of genetically modified species are majorly driving this segment revenue growth. Among rodent based testing, mice are the most extensively used animal.
In terms of indication type, the oncology segment is predicted to hold the largest revenue share in the global market going ahead, owing to the increasing incidence of cancer cases globally, and rising focus of pharmaceutical players on introducing new drugs with fewer side-effects for treating cancer.
North America market dominated other regional markets in terms of revenue share in 2020 with major contribution from U.S. Moreover, growing funding has further boosted the research activities in the region. Increasing healthcare spending, and availability of funding and grants from government organizations such as the National Institute of Health (NIH) to foster research activities are a few factors also promoting the revenue growth of the regional market. Rising RD activities, and growing need for reducing overall trial expenditure are the two major factors expected to augment the demand for in vivo CROs in North America.

Thank you for reading our report. For further inquiry, please connect with us and our team will make sure the report is customized according to your requirements.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com